Physician

Bryant C Sheh, MD

According to 2025 Medicare claims, Bryant Sheh, MD (NPI: 1801092242) practices hematology/oncology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is SUTTER BAY MEDICAL FOUNDATION (NPI: 1013950807; TIN: 941156581) and primary practice location at 94538-2299. Sheh is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Sheh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 668 traditional Medicare patients, billed 184,581 HCPCS/CPT codes, and received $3,367,532 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,276 prescription claims across 216 beneficiaries totaling $3,123,233 in drug costs, led by Xtandi (Enzalutamide). DME data shows 32 claims. Open Payments data shows 6 records totaling $147. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $664,603 to $3,367,532. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $506,519 to $3,123,233. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,798 and ending at $1,487.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	370	40,024	$664,603
2016	412	1,719	$118,865
2017	518	59,534	$869,474
2018	380	98,034	$1,359,471
2019	431	115,188	$2,010,846
2020	427	120,333	$2,508,513
2021	506	135,322	$2,944,448
2022	653	182,428	$2,786,747
2023	655	161,479	$2,460,650
2024	668	184,581	$3,367,532

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	150	818	$506,519
2016	196	1,298	$1,188,349
2017	199	851	$1,207,191
2018	108	855	$1,854,486
2019	148	809	$1,389,620
2020	154	1,074	$1,987,467
2021	154	1,124	$2,602,990
2022	165	1,108	$2,472,215
2023	176	993	$3,080,882
2024	216	1,276	$3,123,233

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	41	$24,422
2016	N/R	68	$7,314
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	33	$1,293
2022	N/R	38	$2,129
2023	N/R	42	$3,682
2024	N/R	32	$739

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	97	469	$139
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	267	556	$116
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	127	272	$65
96372	Injection of drug or substance under skin or into muscle	128	326	$14
J7050	Infusion, normal saline solution, 250 cc	150	364	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	45	1,350	$558,931
Lenalidomide	Lenalidomide	26	644	$287,466
Verzenio	Abemaciclib	17	476	$247,999
Imbruvica	Ibrutinib	15	438	$247,125
Brukinsa	Zanubrutinib	16	480	$230,208

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	15	$525
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	17	$213

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$147	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bryant C. Sheh, MD?

Tedicare shows public-source Medicare data for Bryant C. Sheh, MD (NPI 1801092242), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bryant C. Sheh, MD have ACO affiliation data?

Bryant C. Sheh, MD is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Bryant C. Sheh, MD?

Bryant C. Sheh, MD is linked to SUTTER BAY MEDICAL FOUNDATION (billing NPI 1013950807) in the available physician profile data.

Does Bryant C. Sheh, MD have Open Payments data?

Bryant C. Sheh, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.